ArticleESC heart failure2025

Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trial.

Jan Biegus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.